These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
276 related articles for article (PubMed ID: 31493143)
1. Crosstalk between 14-3-3θ and AF4 enhances MLL-AF4 activity and promotes leukemia cell proliferation. Fioretti T; Cevenini A; Zanobio M; Raia M; Sarnataro D; Salvatore F; Esposito G Cell Oncol (Dordr); 2019 Dec; 42(6):829-845. PubMed ID: 31493143 [TBL] [Abstract][Full Text] [Related]
2. MiR-27a downregulates 14-3-3θ, RUNX1, AF4, and MLL-AF4, crucial drivers of blast transformation in t(4;11) leukemia cells. Fioretti T; Zanobio M; Raia M; Errichiello S; Izzo B; Cattaneo F; Ammendola R; Cevenini A; Esposito G Cell Biochem Funct; 2022 Oct; 40(7):706-717. PubMed ID: 35981137 [TBL] [Abstract][Full Text] [Related]
3. Nuclear FGFR2 Interacts with the MLL-AF4 Oncogenic Chimera and Positively Regulates Fioretti T; Cevenini A; Zanobio M; Raia M; Sarnataro D; Cattaneo F; Ammendola R; Esposito G Int J Mol Sci; 2021 Apr; 22(9):. PubMed ID: 33924850 [TBL] [Abstract][Full Text] [Related]
4. Leukemic fusion genes MLL/AF4 and AML1/MTG8 support leukemic self-renewal by controlling expression of the telomerase subunit TERT. Gessner A; Thomas M; Castro PG; Büchler L; Scholz A; Brümmendorf TH; Soria NM; Vormoor J; Greil J; Heidenreich O Leukemia; 2010 Oct; 24(10):1751-9. PubMed ID: 20686504 [TBL] [Abstract][Full Text] [Related]
5. Methylation-mediated repression of microRNA-143 enhances MLL-AF4 oncogene expression. Dou L; Zheng D; Li J; Li Y; Gao L; Wang L; Yu L Oncogene; 2012 Jan; 31(4):507-17. PubMed ID: 21706045 [TBL] [Abstract][Full Text] [Related]
6. The heterodimerization domains of MLL-FYRN and FYRC--are potential target structures in t(4;11) leukemia. Pless B; Oehm C; Knauer S; Stauber RH; Dingermann T; Marschalek R Leukemia; 2011 Apr; 25(4):663-70. PubMed ID: 21233834 [TBL] [Abstract][Full Text] [Related]
7. MicroRNA-142-3p inhibits cell proliferation in human acute lymphoblastic leukemia by targeting the MLL-AF4 oncogene. Dou L; Li J; Zheng D; Li Y; Gao X; Xu C; Gao L; Wang L; Yu L Mol Biol Rep; 2013 Dec; 40(12):6811-9. PubMed ID: 24057258 [TBL] [Abstract][Full Text] [Related]
8. MLL-AF4 binds directly to a BCL-2 specific enhancer and modulates H3K27 acetylation. Godfrey L; Kerry J; Thorne R; Repapi E; Davies JO; Tapia M; Ballabio E; Hughes JR; Geng H; Konopleva M; Milne TA Exp Hematol; 2017 Mar; 47():64-75. PubMed ID: 27856324 [TBL] [Abstract][Full Text] [Related]
9. AF4 encodes a ubiquitous protein that in both native and MLL-AF4 fusion types localizes to subnuclear compartments. Li Q; Frestedt JL; Kersey JH Blood; 1998 Nov; 92(10):3841-7. PubMed ID: 9808577 [TBL] [Abstract][Full Text] [Related]
10. AF4 and AF4-MLL mediate transcriptional elongation of 5-lipoxygenase mRNA by 1, 25-dihydroxyvitamin D3. Ahmad K; Scholz B; Capelo R; Schweighöfer I; Kahnt AS; Marschalek R; Steinhilber D Oncotarget; 2015 Sep; 6(28):25784-800. PubMed ID: 26329759 [TBL] [Abstract][Full Text] [Related]
11. The AF4.MLL fusion protein is capable of inducing ALL in mice without requirement of MLL.AF4. Bursen A; Schwabe K; Rüster B; Henschler R; Ruthardt M; Dingermann T; Marschalek R Blood; 2010 Apr; 115(17):3570-9. PubMed ID: 20194896 [TBL] [Abstract][Full Text] [Related]
12. Clinical significance of MLL-AF4 fusion transcript expression in the absence of a cytogenetically detectable t(4;11)(q21;q23) chromosomal translocation. Uckun FM; Herman-Hatten K; Crotty ML; Sensel MG; Sather HN; Tuel-Ahlgren L; Sarquis MB; Bostrom B; Nachman JB; Steinherz PG; Gaynon PS; Heerema N Blood; 1998 Aug; 92(3):810-21. PubMed ID: 9680349 [TBL] [Abstract][Full Text] [Related]
13. circRNA circAF4 functions as an oncogene to regulate MLL-AF4 fusion protein expression and inhibit MLL leukemia progression. Huang W; Fang K; Chen TQ; Zeng ZC; Sun YM; Han C; Sun LY; Chen ZH; Yang QQ; Pan Q; Luo XQ; Wang WT; Chen YQ J Hematol Oncol; 2019 Oct; 12(1):103. PubMed ID: 31623653 [TBL] [Abstract][Full Text] [Related]
14. Cryptic splice site activation during RNA processing of MLL/AF4 chimeric transcripts in infants with t(4;11) positive ALL. Divoky V; Trka JM; Watzinger F; Lion T Gene; 2000 Apr; 247(1-2):111-8. PubMed ID: 10773450 [TBL] [Abstract][Full Text] [Related]
15. Pro-B-cell to pre-B-cell development in B-lineage acute lymphoblastic leukemia expressing the MLL/AF4 fusion protein. Bertrand FE; Vogtenhuber C; Shah N; LeBien TW Blood; 2001 Dec; 98(12):3398-405. PubMed ID: 11719380 [TBL] [Abstract][Full Text] [Related]
16. Targeting MLL-AF4 with short interfering RNAs inhibits clonogenicity and engraftment of t(4;11)-positive human leukemic cells. Thomas M; Gessner A; Vornlocher HP; Hadwiger P; Greil J; Heidenreich O Blood; 2005 Nov; 106(10):3559-66. PubMed ID: 16046533 [TBL] [Abstract][Full Text] [Related]
17. AAV8 vector expressing IL24 efficiently suppresses tumor growth mediated by specific mechanisms in MLL/AF4-positive ALL model mice. Tamai H; Miyake K; Yamaguchi H; Takatori M; Dan K; Inokuchi K; Shimada T Blood; 2012 Jan; 119(1):64-71. PubMed ID: 22025528 [TBL] [Abstract][Full Text] [Related]
18. B-cell development in the presence of the MLL/AF4 oncoprotein proceeds in the absence of HOX A7 and HOX A9 expression. Bertrand FE; Spengeman JD; Shah N; LeBien TW Leukemia; 2003 Dec; 17(12):2454-9. PubMed ID: 14562113 [TBL] [Abstract][Full Text] [Related]
19. miR-130b and miR-128a are essential lineage-specific codrivers of t(4;11) MLL-AF4 acute leukemia. Malouf C; Antunes ETB; O'Dwyer M; Jakobczyk H; Sahm F; Landua SL; Anderson RA; Soufi A; Halsey C; Ottersbach K Blood; 2021 Nov; 138(21):2066-2092. PubMed ID: 34111240 [TBL] [Abstract][Full Text] [Related]